Literature DB >> 17968334

Mechanisms of Disease: angiogenesis in inflammatory diseases.

Zoltán Szekanecz1, Alisa E Koch.   

Abstract

Angiogenesis, the development of new vessels, is an important process in health and disease. The perpetuation of neovascularization in inflammatory diseases, such as rheumatoid arthritis, spondyloarthropathies and some systemic autoimmune diseases, might facilitate the ingress of inflammatory cells into the synovium and, therefore, stimulate pannus formation. Disorders associated with perpetuated neovascularization are considered to be angiogenic inflammatory diseases. Several angiogenic mediators, including growth factors, cytokines, matrix metalloproteinases, matrix macromolecules, cell adhesion receptors, chemokines and chemokine receptors, have been implicated in the process of capillary formation. There is a regulatory network in inflamed tissues that is involved in the upregulation or downregulation of angiogenesis. Endogenous angiostatic factors downregulate neovascularization and might act as angiostatic agents. Furthermore, angiogenesis might be targeted by several specific approaches that could be therapeutically used to control inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17968334     DOI: 10.1038/ncprheum0647

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN: 1745-8382


  64 in total

Review 1.  Intervertebral disc, sensory nerves and neurotrophins: who is who in discogenic pain?

Authors:  José García-Cosamalón; Miguel E del Valle; Marta G Calavia; Olivia García-Suárez; Alfonso López-Muñiz; Jesús Otero; José A Vega
Journal:  J Anat       Date:  2010-04-26       Impact factor: 2.610

2.  IL-17 contributes to angiogenesis in rheumatoid arthritis.

Authors:  Sarah R Pickens; Michael V Volin; Arthur M Mandelin; Jay K Kolls; Richard M Pope; Shiva Shahrara
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

3.  Angiogenic growth factors in rheumatoid arthritis.

Authors:  Malte Schroeder; Lennart Viezens; Ina Fuhrhop; Wolfgang Rüther; Christian Schaefer; Britta Schwarzloh; Petra Algenstaedt; Bernd Fink; Nils Hansen-Algenstaedt
Journal:  Rheumatol Int       Date:  2011-11-09       Impact factor: 2.631

Review 4.  Cardiovascular actions of neurotrophins.

Authors:  Andrea Caporali; Costanza Emanueli
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 5.  Putative effects of potentially anti-angiogenic drugs in rheumatic diseases.

Authors:  Nicola Maruotti; Francesco Paolo Cantatore; Domenico Ribatti
Journal:  Eur J Clin Pharmacol       Date:  2013-11-07       Impact factor: 2.953

6.  The investigation of synovial genomic targets of bucillamine with microarray technique.

Authors:  Kenji Oki; Fumio Tsuji; Koji Ohashi; Masaaki Kageyama; Hiroyuki Aono; Minoru Sasano
Journal:  Inflamm Res       Date:  2009-03-17       Impact factor: 4.575

7.  A comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients.

Authors:  Imran H Khan; V V Krishnan; Melanie Ziman; Kim Janatpour; Ted Wun; Paul A Luciw; Joseph Tuscano
Journal:  Cytometry B Clin Cytom       Date:  2009-05       Impact factor: 3.058

8.  Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis.

Authors:  Mohammed A Akhavani; Leigh Madden; Ian Buysschaert; Branavan Sivakumar; Norbert Kang; Ewa M Paleolog
Journal:  Arthritis Res Ther       Date:  2009-05-08       Impact factor: 5.156

9.  Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis.

Authors:  Christian Barthel; Nataliya Yeremenko; Roland Jacobs; Reinhold E Schmidt; Michael Bernateck; Henning Zeidler; Paul-Peter Tak; Dominique Baeten; Markus Rihl
Journal:  Arthritis Res Ther       Date:  2009-06-02       Impact factor: 5.156

10.  Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy.

Authors:  Elena Izquierdo; Juan D Cañete; Raquel Celis; Begoña Santiago; Alicia Usategui; Raimon Sanmartí; Manuel J Del Rey; José L Pablos
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.